Sign In
Buy TGTX
$40.11
+3.47 (+9.47%)
At Close: Jun 03, 2026
TG Therapeutics (TGTX) Stock Moves -0.89%: What You Should Know
11:00pm, Monday, 30'th Jan 2023 Zacks Investment Research
In the latest trading session, TG Therapeutics (TGTX) closed at $14.50, marking a -0.89% move from the previous day.
TG Therapeutics Announces Commercial Launch of BRIUMVI™ (ublituximab-xiiy) for the Treatment of Adult Patients with Relapsing Forms of Multiple Sclerosis
12:00pm, Thursday, 26'th Jan 2023 GlobeNewswire Inc.
NEW YORK, Jan. 26, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the commercial launch of BRIUMVI™ (ublituximab-xiiy), for the treatment of relapsing forms of multi
The Latest Analyst Ratings for TG Therapeutics
05:01pm, Tuesday, 24'th Jan 2023 Benzinga
Within the last quarter, TG Therapeutics (NASDAQ:TGTX) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
2
0
1
1
Last
TG Therapeutics (TGTX) Outpaces Stock Market Gains: What You Should Know
11:00pm, Thursday, 12'th Jan 2023 Zacks Investment Research
TG Therapeutics (TGTX) closed at $13.20 in the latest trading session, marking a +0.61% move from the prior day.
TG Therapeutics (TGTX) Soars 8.7%: Is Further Upside Left in the Stock?
12:06pm, Thursday, 12'th Jan 2023 Zacks Investment Research
TG Therapeutics (TGTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
TG Therapeutics (TGTX) Soars 8.7%: Is Further Upside Left in the Stock?
08:17am, Thursday, 12'th Jan 2023
TG Therapeutics (TGTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
TG Therapeutics (TGTX) Upgraded to Buy: What Does It Mean for the Stock?
05:00pm, Monday, 09'th Jan 2023 Zacks Investment Research
TG Therapeutics (TGTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TG Therapeutics (TGTX) Upgraded to Buy: What Does It Mean for the Stock?
01:33pm, Monday, 09'th Jan 2023
TG Therapeutics (TGTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TG Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
12:30pm, Friday, 06'th Jan 2023 GlobeNewswire Inc.
Presentation scheduled for Monday, January 9, 2023 at 9:45 AM PT Presentation scheduled for Monday, January 9, 2023 at 9:45 AM PT
TG Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
07:30am, Friday, 06'th Jan 2023
Presentation scheduled for Monday, January 9, 2023 at 9:45 AM PT Presentation scheduled for Monday, January 9, 2023 at 9:45 AM PT
EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In December 2022: Where Do Tesla, Apple, AMC Rank?
11:54pm, Tuesday, 03'rd Jan 2023 Benzinga
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.
Here is a look at the most
Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket
12:55pm, Tuesday, 03'rd Jan 2023 Benzinga
Gainers
Gorilla Technology Group Inc. (NASDAQ: GRRR) shares rose 162% to $21.30 in pre-market trading after jumping over 35% on Friday. Gorilla Technology recently said it is entering the MENA regio
TG Therapeutics: Ramifications Of Briumvi Approval
01:04pm, Monday, 02'nd Jan 2023
TG Therapeutics, Inc. is set to launch Briumvi with an experienced in-house team. There are several factors conducive to launch success. Nevertheless, uncertainty remains.
MDA Breakout Stocks Week 1 - January 2023: High-Frequency Gainers To Give You An Edge
10:12am, Monday, 02'nd Jan 2023
Two new Breakout Stocks for Week 1 with better than 10% short-term upside potential and two Dow 30 Picks. Average cumulative returns for 2022 reached +142.69% YTD. The streak of weekly picks gaining o
Why TG Therapeutics Stock Was a Solid Winner This Week
10:27pm, Friday, 30'th Dec 2022 The Motley Fool
The company scored a giant victory on the regulatory front.
